Literature DB >> 25801635

A new chance to beat diabetic kidney disease: innate immunity and MCP-1: a matter of good and bad macrophages?

Luigi Gnudi1.   

Abstract

Entities:  

Year:  2015        PMID： 25801635     DOI： 10.1093/ndt/gfv053

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

Review 1.  Innate immunity in diabetes and diabetic nephropathy.

Authors:  Jun Wada; Hirofumi Makino
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

Review 2.  Macrophage in chronic kidney disease.

Authors:  Roser Guiteras; Maria Flaquer; Josep M Cruzado
Journal:  Clin Kidney J       Date:  2016-10-05

3.  C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.

Authors:  Jan Menne; Dirk Eulberg; Diana Beyer; Matthias Baumann; Frantisek Saudek; Zsuzsanna Valkusz; Andrzej Więcek; Hermann Haller
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

4.  The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A.

Authors:  R Wagner; J Machann; M Guthoff; P P Nawroth; S Nadalin; M A Saleem; N Heyne; A Königsrainer; F Fend; F Schick; A Fritsche; N Stefan; H-U Häring; E Schleicher; D I Siegel-Axel
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

5.  Exploring macrophage cell therapy on Diabetic Kidney Disease.

Authors:  Roser Guiteras; Anna Sola; Maria Flaquer; Anna Manonelles; Georgina Hotter; Josep M Cruzado
Journal:  J Cell Mol Med       Date:  2018-11-08       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.